Concepts (230)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extracellular Matrix Proteins | 5 | 2015 | 67 | 0.910 |
Why?
|
| Transforming Growth Factor beta | 5 | 2015 | 197 | 0.840 |
Why?
|
| Gaucher Disease | 1 | 2016 | 3 | 0.570 |
Why?
|
| Proteoglycans | 3 | 2014 | 47 | 0.500 |
Why?
|
| Long-Term Potentiation | 2 | 2005 | 102 | 0.460 |
Why?
|
| Transforming Growth Factor beta1 | 3 | 2009 | 93 | 0.420 |
Why?
|
| Estradiol | 1 | 2014 | 262 | 0.410 |
Why?
|
| Transcription, Genetic | 2 | 2014 | 578 | 0.400 |
Why?
|
| Osteosarcoma | 1 | 2009 | 26 | 0.340 |
Why?
|
| Bone Neoplasms | 1 | 2009 | 45 | 0.330 |
Why?
|
| Extracellular Matrix | 3 | 2004 | 115 | 0.320 |
Why?
|
| Versicans | 6 | 2010 | 8 | 0.300 |
Why?
|
| Peptide Fragments | 1 | 2009 | 308 | 0.290 |
Why?
|
| Apoptosis | 3 | 2015 | 1398 | 0.280 |
Why?
|
| Chondrocytes | 4 | 2014 | 16 | 0.280 |
Why?
|
| Fibroblasts | 4 | 2016 | 272 | 0.250 |
Why?
|
| Electroencephalography | 1 | 2005 | 116 | 0.240 |
Why?
|
| Cell-Matrix Junctions | 1 | 2003 | 2 | 0.230 |
Why?
|
| Theta Rhythm | 1 | 2003 | 7 | 0.220 |
Why?
|
| Hippocampus | 2 | 2005 | 561 | 0.220 |
Why?
|
| Oligopeptides | 1 | 2003 | 102 | 0.210 |
Why?
|
| Animals | 15 | 2016 | 15081 | 0.200 |
Why?
|
| Muscle, Skeletal | 1 | 2003 | 282 | 0.190 |
Why?
|
| Cell Adhesion | 5 | 2003 | 212 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2008 | 643 | 0.180 |
Why?
|
| Cell Line | 3 | 2015 | 1354 | 0.160 |
Why?
|
| Integrins | 2 | 2009 | 51 | 0.140 |
Why?
|
| Pyrrolidines | 1 | 2016 | 29 | 0.140 |
Why?
|
| Exons | 2 | 2014 | 88 | 0.140 |
Why?
|
| Dogs | 1 | 2016 | 149 | 0.140 |
Why?
|
| Kinetics | 1 | 2016 | 708 | 0.120 |
Why?
|
| 5' Flanking Region | 1 | 2014 | 4 | 0.120 |
Why?
|
| Papio | 1 | 2014 | 22 | 0.120 |
Why?
|
| Retroviridae | 1 | 2014 | 22 | 0.120 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 433 | 0.120 |
Why?
|
| Response Elements | 1 | 2014 | 56 | 0.120 |
Why?
|
| Oxidative Stress | 2 | 2010 | 938 | 0.120 |
Why?
|
| Conserved Sequence | 1 | 2014 | 119 | 0.120 |
Why?
|
| Alternative Splicing | 1 | 2014 | 85 | 0.120 |
Why?
|
| Genes, Reporter | 1 | 2014 | 136 | 0.120 |
Why?
|
| Electric Stimulation | 2 | 2005 | 184 | 0.120 |
Why?
|
| Amino Acid Sequence | 2 | 2009 | 1180 | 0.120 |
Why?
|
| Genetic Vectors | 1 | 2014 | 158 | 0.120 |
Why?
|
| Cell Culture Techniques | 1 | 2014 | 142 | 0.110 |
Why?
|
| RNA, Messenger | 3 | 2014 | 1207 | 0.110 |
Why?
|
| Analysis of Variance | 3 | 2010 | 550 | 0.110 |
Why?
|
| Transfection | 1 | 2014 | 523 | 0.110 |
Why?
|
| Estrogens | 1 | 2014 | 202 | 0.110 |
Why?
|
| Retina | 1 | 2015 | 280 | 0.100 |
Why?
|
| Endothelial Cells | 1 | 2015 | 308 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 515 | 0.100 |
Why?
|
| Computer Simulation | 1 | 2014 | 362 | 0.100 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 2003 | 286 | 0.100 |
Why?
|
| Macrophages | 1 | 2015 | 439 | 0.100 |
Why?
|
| Humans | 12 | 2016 | 37093 | 0.090 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2010 | 35 | 0.090 |
Why?
|
| Immunohistochemistry | 4 | 2010 | 893 | 0.090 |
Why?
|
| Macrophages, Peritoneal | 1 | 2009 | 23 | 0.090 |
Why?
|
| Receptors, LDL | 1 | 2009 | 30 | 0.080 |
Why?
|
| Hypercholesterolemia | 1 | 2009 | 38 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2005 | 1618 | 0.080 |
Why?
|
| Cell Line, Tumor | 3 | 2010 | 2231 | 0.080 |
Why?
|
| Cells, Cultured | 4 | 2009 | 1518 | 0.080 |
Why?
|
| Prostatic Hyperplasia | 1 | 2009 | 34 | 0.080 |
Why?
|
| Female | 8 | 2014 | 20969 | 0.080 |
Why?
|
| Proteomics | 1 | 2010 | 325 | 0.080 |
Why?
|
| Rats | 3 | 2005 | 3483 | 0.080 |
Why?
|
| Atherosclerosis | 1 | 2009 | 134 | 0.080 |
Why?
|
| Kidney Diseases | 1 | 2009 | 167 | 0.070 |
Why?
|
| Interleukin-1beta | 1 | 2007 | 70 | 0.070 |
Why?
|
| Ovarian Neoplasms | 1 | 2010 | 312 | 0.070 |
Why?
|
| Biocompatible Materials | 2 | 2004 | 76 | 0.070 |
Why?
|
| Cycloheximide | 2 | 2003 | 30 | 0.070 |
Why?
|
| Texas | 1 | 2008 | 324 | 0.070 |
Why?
|
| Mice | 4 | 2009 | 5913 | 0.070 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2007 | 86 | 0.070 |
Why?
|
| Fibronectins | 2 | 2003 | 66 | 0.070 |
Why?
|
| Protein Binding | 1 | 2009 | 972 | 0.070 |
Why?
|
| Polyesters | 2 | 2004 | 25 | 0.070 |
Why?
|
| Stromal Cells | 2 | 2004 | 49 | 0.070 |
Why?
|
| Mexican Americans | 1 | 2008 | 189 | 0.070 |
Why?
|
| Hydrogels | 2 | 2004 | 37 | 0.070 |
Why?
|
| Male | 6 | 2009 | 20025 | 0.070 |
Why?
|
| Rural Population | 1 | 2008 | 294 | 0.070 |
Why?
|
| Polyethylene Glycols | 2 | 2004 | 84 | 0.060 |
Why?
|
| Breast Neoplasms | 3 | 2014 | 1502 | 0.060 |
Why?
|
| Procollagen N-Endopeptidase | 1 | 2005 | 1 | 0.060 |
Why?
|
| Disintegrins | 1 | 2005 | 2 | 0.060 |
Why?
|
| Extracellular Space | 1 | 2005 | 35 | 0.060 |
Why?
|
| Metalloendopeptidases | 1 | 2005 | 16 | 0.060 |
Why?
|
| Ovulation | 1 | 2005 | 20 | 0.060 |
Why?
|
| Electrophysiology | 1 | 2005 | 136 | 0.060 |
Why?
|
| Excitatory Postsynaptic Potentials | 1 | 2005 | 79 | 0.060 |
Why?
|
| Ovarian Follicle | 1 | 2005 | 35 | 0.060 |
Why?
|
| Osteogenesis | 1 | 2004 | 35 | 0.060 |
Why?
|
| Tenascin | 1 | 2004 | 6 | 0.060 |
Why?
|
| Chondroitin Sulfates | 1 | 2004 | 9 | 0.060 |
Why?
|
| Oocytes | 1 | 2005 | 146 | 0.060 |
Why?
|
| Bone Marrow Cells | 1 | 2004 | 81 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 628 | 0.060 |
Why?
|
| Hyaluronic Acid | 1 | 2004 | 33 | 0.060 |
Why?
|
| Microscopy, Immunoelectron | 1 | 2003 | 34 | 0.060 |
Why?
|
| Embryonic and Fetal Development | 1 | 2003 | 37 | 0.060 |
Why?
|
| Edetic Acid | 1 | 2003 | 23 | 0.060 |
Why?
|
| Histocytochemistry | 1 | 2003 | 50 | 0.060 |
Why?
|
| Collagen Type I | 1 | 2003 | 30 | 0.060 |
Why?
|
| Myoblasts | 1 | 2003 | 27 | 0.060 |
Why?
|
| In Situ Hybridization | 1 | 2003 | 129 | 0.060 |
Why?
|
| Mesoderm | 1 | 2003 | 70 | 0.060 |
Why?
|
| Organ Specificity | 1 | 2003 | 129 | 0.060 |
Why?
|
| Laminin | 1 | 2003 | 61 | 0.060 |
Why?
|
| Muscle Development | 1 | 2003 | 45 | 0.060 |
Why?
|
| Prevalence | 1 | 2008 | 1455 | 0.060 |
Why?
|
| Cell Adhesion Molecules | 1 | 2003 | 75 | 0.050 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2003 | 64 | 0.050 |
Why?
|
| Antibodies | 1 | 2003 | 141 | 0.050 |
Why?
|
| Cytological Techniques | 1 | 2002 | 15 | 0.050 |
Why?
|
| Neuronal Plasticity | 1 | 2003 | 103 | 0.050 |
Why?
|
| Recombinant Proteins | 1 | 2003 | 515 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 3 | 2015 | 1609 | 0.050 |
Why?
|
| Blotting, Western | 1 | 2003 | 859 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2003 | 1568 | 0.050 |
Why?
|
| Signal Transduction | 3 | 2015 | 1908 | 0.040 |
Why?
|
| Time Factors | 3 | 2014 | 1742 | 0.040 |
Why?
|
| Risk Factors | 1 | 2008 | 3562 | 0.040 |
Why?
|
| Lectins, C-Type | 3 | 2004 | 36 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 623 | 0.040 |
Why?
|
| Middle Aged | 3 | 2008 | 10129 | 0.040 |
Why?
|
| Up-Regulation | 2 | 2010 | 513 | 0.040 |
Why?
|
| Mice, Knockout | 2 | 2015 | 933 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 1371 | 0.040 |
Why?
|
| Adult | 3 | 2008 | 11712 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 935 | 0.030 |
Why?
|
| Retinal Vessels | 1 | 2015 | 24 | 0.030 |
Why?
|
| Macaca mulatta | 1 | 2015 | 128 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2003 | 935 | 0.030 |
Why?
|
| Culture Media, Conditioned | 2 | 2003 | 46 | 0.030 |
Why?
|
| Disease-Free Survival | 2 | 2004 | 113 | 0.030 |
Why?
|
| Lymph Nodes | 2 | 2004 | 67 | 0.030 |
Why?
|
| Molecular Weight | 2 | 2003 | 167 | 0.030 |
Why?
|
| Cartilage, Articular | 2 | 2002 | 9 | 0.030 |
Why?
|
| Rabbits | 2 | 2003 | 283 | 0.030 |
Why?
|
| Stress, Mechanical | 2 | 2003 | 113 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 2003 | 502 | 0.020 |
Why?
|
| Rotenone | 1 | 2010 | 19 | 0.020 |
Why?
|
| Cell Growth Processes | 1 | 2010 | 41 | 0.020 |
Why?
|
| Heat-Shock Proteins | 1 | 2010 | 55 | 0.020 |
Why?
|
| Insecticides | 1 | 2010 | 51 | 0.020 |
Why?
|
| Cricetulus | 1 | 2010 | 80 | 0.020 |
Why?
|
| CHO Cells | 1 | 2010 | 124 | 0.020 |
Why?
|
| Cricetinae | 1 | 2010 | 238 | 0.020 |
Why?
|
| Endoplasmic Reticulum | 1 | 2010 | 105 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2010 | 207 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 2010 | 129 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2010 | 275 | 0.020 |
Why?
|
| Streptozocin | 1 | 2009 | 21 | 0.020 |
Why?
|
| Blood Chemical Analysis | 1 | 2009 | 21 | 0.020 |
Why?
|
| Urinalysis | 1 | 2009 | 30 | 0.020 |
Why?
|
| Neovascularization, Pathologic | 1 | 2010 | 127 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 251 | 0.020 |
Why?
|
| Proteome | 1 | 2010 | 144 | 0.020 |
Why?
|
| Probability | 1 | 2009 | 78 | 0.020 |
Why?
|
| Sulfhydryl Compounds | 1 | 2009 | 47 | 0.020 |
Why?
|
| Chemotaxis | 1 | 2009 | 60 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2010 | 448 | 0.020 |
Why?
|
| Glycosaminoglycans | 1 | 2009 | 22 | 0.020 |
Why?
|
| Random Allocation | 1 | 2009 | 139 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2004 | 1492 | 0.020 |
Why?
|
| Organ Size | 1 | 2009 | 157 | 0.020 |
Why?
|
| Prostatectomy | 1 | 2009 | 63 | 0.020 |
Why?
|
| DNA, Complementary | 1 | 2009 | 191 | 0.020 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2009 | 94 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2009 | 431 | 0.020 |
Why?
|
| Sulfur Radioisotopes | 1 | 2007 | 7 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 1039 | 0.020 |
Why?
|
| Sulfates | 1 | 2007 | 23 | 0.020 |
Why?
|
| Prostate | 1 | 2009 | 154 | 0.020 |
Why?
|
| Cell Survival | 1 | 2010 | 864 | 0.020 |
Why?
|
| Mice, Transgenic | 1 | 2009 | 617 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2007 | 150 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2007 | 201 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2004 | 2379 | 0.020 |
Why?
|
| RNA | 1 | 2009 | 241 | 0.020 |
Why?
|
| Arteries | 1 | 2007 | 65 | 0.020 |
Why?
|
| Amino Acids | 1 | 2007 | 145 | 0.020 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2007 | 130 | 0.020 |
Why?
|
| Matrix Metalloproteinases, Membrane-Associated | 1 | 2005 | 1 | 0.020 |
Why?
|
| Syndecans | 1 | 2005 | 2 | 0.020 |
Why?
|
| ADAM Proteins | 1 | 2005 | 16 | 0.020 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2005 | 43 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2005 | 48 | 0.020 |
Why?
|
| Sialoglycoproteins | 1 | 2004 | 11 | 0.020 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2010 | 807 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 2004 | 50 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2005 | 81 | 0.020 |
Why?
|
| Dexamethasone | 1 | 2004 | 45 | 0.020 |
Why?
|
| Materials Testing | 1 | 2004 | 69 | 0.020 |
Why?
|
| Osteopontin | 1 | 2004 | 36 | 0.020 |
Why?
|
| Ovary | 1 | 2005 | 108 | 0.010 |
Why?
|
| Cell Count | 1 | 2004 | 135 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2004 | 233 | 0.010 |
Why?
|
| Risk | 1 | 2004 | 267 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2005 | 211 | 0.010 |
Why?
|
| Phalloidine | 1 | 2003 | 1 | 0.010 |
Why?
|
| Rhodamines | 1 | 2003 | 21 | 0.010 |
Why?
|
| Micromanipulation | 1 | 2003 | 12 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2004 | 455 | 0.010 |
Why?
|
| Base Sequence | 1 | 2005 | 997 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 2003 | 110 | 0.010 |
Why?
|
| Transducers | 1 | 2002 | 12 | 0.010 |
Why?
|
| Mechanics | 1 | 2002 | 3 | 0.010 |
Why?
|
| Elasticity | 1 | 2002 | 38 | 0.010 |
Why?
|
| Absorption | 1 | 2002 | 25 | 0.010 |
Why?
|
| Tensile Strength | 1 | 2002 | 25 | 0.010 |
Why?
|
| Equipment Design | 1 | 2002 | 124 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2003 | 181 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2002 | 176 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 2002 | 130 | 0.010 |
Why?
|
| Species Specificity | 1 | 2002 | 245 | 0.010 |
Why?
|
| Tissue Engineering | 1 | 2002 | 60 | 0.010 |
Why?
|
| Calcium | 1 | 2004 | 480 | 0.010 |
Why?
|
| Aged | 2 | 2004 | 6741 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2002 | 128 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2004 | 587 | 0.010 |
Why?
|
| Cattle | 1 | 2002 | 477 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2003 | 381 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2002 | 562 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2004 | 1369 | 0.010 |
Why?
|
| Water | 1 | 2002 | 296 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 1015 | 0.010 |
Why?
|